Literature DB >> 20232599

Stem cell divisions controlled by the proto-oncogene BMI-1.

Edgar Grinstein1, Csaba Mahotka.   

Abstract

Divisions of somatic stem cells are required for the maintenance and regeneration of normal tissues, while divisions of cancerous stem cells likely underlie the existence of certain malignant diseases. Studies of recent years suggest that molecular mechanisms governing stem cell self-renewal can be subverted in tumorigenesis to maintain cancerous growth. This is exemplified by the proto-oncogene BMI-1 that is involved in the maintenance of somatic stem cells and in carcinogenesis within the same tissues. BMI-1 interferes with the central cellular tumor suppressor pathways linked to retinoblastoma protein (Rb) and p53. These signaling pathways control the cell cycle, cell differentiation, cellular senescence and cell death. While the roles of the pathways associated with Rb and p53 in cancer are broadly established, further elucidation thereof in stem cells might have implications in cancer research, stem cell biology and regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20232599

Source DB:  PubMed          Journal:  J Stem Cells        ISSN: 1556-8539


  16 in total

1.  Bmi1 facilitates primitive endoderm formation by stabilizing Gata6 during early mouse development.

Authors:  Fabrice Lavial; Sylvain Bessonnard; Yusuke Ohnishi; Akiko Tsumura; Anil Chandrashekran; Mark A Fenwick; Rute A Tomaz; Hiroyuki Hosokawa; Toshinori Nakayama; Ian Chambers; Takashi Hiiragi; Claire Chazaud; Véronique Azuara
Journal:  Genes Dev       Date:  2012-06-19       Impact factor: 11.361

2.  New functions for the Snail family of transcription factors: Two-faced proteins.

Authors:  Jesús Pérez-Losada; Isidro Sanchez-Garcia
Journal:  Cell Cycle       Date:  2010-07-15       Impact factor: 4.534

Review 3.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

Review 4.  DNA damage response in adult stem cells: pathways and consequences.

Authors:  Pankaj K Mandal; Cédric Blanpain; Derrick J Rossi
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02-09       Impact factor: 94.444

5.  Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.

Authors:  Monica Bartucci; Mohamed S Hussein; Eric Huselid; Kathleen Flaherty; Michele Patrizii; Saurabh V Laddha; Cindy Kui; Rachel A Bigos; John A Gilleran; Mervat M S El Ansary; Mona A M Awad; S David Kimball; David J Augeri; Hatem E Sabaawy
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

6.  BMI-1, a promising therapeutic target for human cancer.

Authors:  Min-Cong Wang; Chun-Li Li; Jie Cui; Min Jiao; Tao Wu; L I Jing; Ke-Jun Nan
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

7.  Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.

Authors:  Ioannis P Gialmanidis; Vasiliki Bravou; Ilias Petrou; Helen Kourea; Alexandros Mathioudakis; Ioannis Lilis; Helen Papadaki
Journal:  Lung       Date:  2013-07-18       Impact factor: 2.584

8.  Bmi-1 absence causes premature brain degeneration.

Authors:  Guangliang Cao; Minxia Gu; Min Zhu; Junying Gao; Ying Yin; Charles Marshall; Ming Xiao; Jiong Ding; Dengshun Miao
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

9.  HDAC inhibitors repress the polycomb protein BMI1.

Authors:  Steven Grant
Journal:  Cell Cycle       Date:  2010-07-15       Impact factor: 4.534

10.  Oncogenicity of the developmental transcription factor Sox9.

Authors:  Ander Matheu; Manuel Collado; Clare Wise; Lorea Manterola; Lina Cekaite; Angela J Tye; Marta Canamero; Luis Bujanda; Andreas Schedl; Kathryn S E Cheah; Rolf I Skotheim; Ragnhild A Lothe; Adolfo López de Munain; James Briscoe; Manuel Serrano; Robin Lovell-Badge
Journal:  Cancer Res       Date:  2012-01-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.